The iShares MSCI World ETF: A Record High Surrounded by a Thicket of Risks

The iShares MSCI World ETF hits $204.65, but faces headwinds from pharma tariffs, potential SpaceX inclusion, and key macro events as RSI nears overbought.

The iShares MSCI World ETF is trading at an all-time high of $204.65, but the celebratory mood is tempered by an unusually dense calendar of events that could reshape the fund’s trajectory. The exchange-traded fund has clocked an 11% gain since January, with a near-4% advance over the past 30 days, yet its relative strength index sits at 67.6 — dangerously close to the overbought threshold of 70. The rally is real, but the air is thinning.

Underpinning that performance is a heavy reliance on a handful of US technology behemoths. The portfolio, which spans more than 1,300 holdings across 23 developed economies, is effectively steered by just a few names: Nvidia commands a 6.36% weighting, Apple 4.86%, and Microsoft 3.21%. US stocks altogether account for 71.91% of the index, leaving the fund acutely exposed to any rotation away from mega-cap tech. The trailing price-to-earnings ratio has climbed above 26, leaving little margin for error if earnings disappoint.

That vulnerability is about to be tested by a fresh batch of US tariffs on pharmaceutical imports. The health-care sector makes up roughly 10% of the fund, and the newly imposed duties hit hard: patented drugs from the EU, Japan, South Korea, and Switzerland face a 15% levy, while British products carry a 10% charge. Companies without existing pricing agreements could be slapped with rates as high as 100%. FactSet has already trimmed earnings expectations for the sector, and the knock-on effect for the ETF could be meaningful.

An even more structural shift looms in the form of SpaceX. The rocket company has filed its IPO prospectus with the SEC, targeting a valuation of roughly $1.75 trillion and an issuance volume of $75 billion — which would make it the largest initial public offering in history. MSCI chief Henry Fernandez has confirmed that the index provider could add SpaceX to its benchmarks just ten trading days after its Nasdaq listing, bypassing the usual three-month waiting period for very large new listings. For a passive vehicle like the iShares MSCI World ETF, that means automatic inclusion with no discretion. Analysts estimate the index-driven buying pressure alone could reach $12 billion, injecting a volatile new component into the fund’s already concentrated mix.

On the macroeconomic front, two key dates loom. On June 5, the Bureau of Labor Statistics releases its May employment report, after April surprised with 115,000 new nonfarm payrolls — nearly double expectations — while the unemployment rate held steady at 4.3%. Then on June 17, Kevin Warsh chairs his first Federal Reserve meeting. Markets assign a 97% probability to no rate change, and for good reason: US inflation stands at 3.8%, a three-year high, while wage growth trails at 3.6%. Goldman Sachs and Bank of America have both scrapped their rate-cut forecasts for 2026 entirely.

The fee landscape is also shifting under the fund’s feet. The iShares MSCI World ETF charges 0.24% in annual expenses and carries a Morningstar Gold rating, supported by a tracking difference of just 0.02%. But competitors are driving fees lower: Invesco has slashed a comparable product to 0.05%, and UBS and BNP Paribas have followed suit. Investors seeking cheaper or more diversified alternatives can turn to the iShares Core MSCI Total International Stock ETF at 0.07% — which fully excludes US stocks — or the iShares MSCI ACWI fund at 0.32%, which adds emerging markets.

For now, the fund sits at a record high with strong inflows — net $1.86 billion over the past twelve months — but the coming weeks will deliver a series of concrete data points that could recalibrate both interest-rate expectations and the portfolio’s composition. The jobs report on June 5 and the Fed meeting on June 17 are the immediate markers. The SpaceX inclusion, meanwhile, is a structural wildcard that passive investors will have no choice but to accept.